Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Harvard Business School
QuintilesIMS
McKinsey
UBS

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 6,759,432

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,759,432
Title: Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
Abstract:The use of an MMP inhibitor, especially a collagenase inhibitor, in the manufacture of a medicament for the treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction of the tissue and methods for the treatment of tissue comprising extracellular matrix components to inhibit contraction.
Inventor(s): Khaw; Peng Tee (London, GB), Schultz; Gregory S. (Gainesville, FL)
Assignee: University of Florida Research Foundation (Gainesville, FL) Moorfields Eye Hospital National Health Service Trust (London, GB) The Institute of Ophthalmology (London, GB)
Application Number:10/135,934
Patent Claims:see list of patent claims

Details for Patent 6,759,432

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up University of Florida Research Foundation (Gainesville, FL) Moorfields Eye Hospital National Health Service Trust (London, GB) The Institute of Ophthalmology (London, GB) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
QuintilesIMS
Merck
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.